Viswanathan S - Search Results

1

Clonal evolution of stem and differentiated cells can be predicted by integrating cell-intrinsic and -extrinsic parameters.

Viswanathan S, Davey RE, Cheng D, Raghu RC, Lauffenburger DA, Zandstra PW. Viswanathan S, et al. Biotechnol Appl Biochem. 2005 Oct;42(Pt 2):119-31. doi: 10.1042/BA20040207. Biotechnol Appl Biochem. 2005. PMID: 15882145

2

Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6.

Viswanathan S, Benatar T, Rose-John S, Lauffenburger DA, Zandstra PW. Viswanathan S, et al. Stem Cells. 2002;20(2):119-38. doi: 10.1634/stemcells.20-2-119. Stem Cells. 2002. PMID: 11897869

3

Supplementation-dependent differences in the rates of embryonic stem cell self-renewal, differentiation, and apoptosis.

Viswanathan S, Benatar T, Mileikovsky M, Lauffenburger DA, Nagy A, Zandstra PW. Viswanathan S, et al. Biotechnol Bioeng. 2003 Dec 5;84(5):505-17. doi: 10.1002/bit.10799. Biotechnol Bioeng. 2003. PMID: 14574685

4

Towards predictive models of stem cell fate.

Viswanathan S, Zandstra PW. Viswanathan S, et al. Cytotechnology. 2003 Mar;41(2-3):75-92. doi: 10.1023/A:1024866504538. Cytotechnology. 2003. PMID: 19002945 Free PMC article.

5

Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.

Swift BE, Williams BA, Kosaka Y, Wang XH, Medin JA, Viswanathan S, Martinez-Lopez J, Keating A. Swift BE, et al. Among authors: viswanathan s. Haematologica. 2012 Jul;97(7):1020-8. doi: 10.3324/haematol.2011.054254. Epub 2012 Jan 22. Haematologica. 2012. PMID: 22271890 Free PMC article.

6

TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.

Rashedi I, Gómez-Aristizábal A, Wang XH, Viswanathan S, Keating A. Rashedi I, et al. Among authors: viswanathan s. Stem Cells. 2017 Jan;35(1):265-275. doi: 10.1002/stem.2485. Epub 2016 Sep 20. Stem Cells. 2017. PMID: 27571579

7

Proceedings: international regulatory considerations on development pathways for cell therapies.

Feigal EG, Tsokas K, Viswanathan S, Zhang J, Priest C, Pearce J, Mount N. Feigal EG, et al. Among authors: viswanathan s. Stem Cells Transl Med. 2014 Aug;3(8):879-87. doi: 10.5966/sctm.2014-0122. Epub 2014 Jul 18. Stem Cells Transl Med. 2014. PMID: 25038248 Free PMC article.

8

A Systematic Study of the Effect of Different Molecular Weights of Hyaluronic Acid on Mesenchymal Stromal Cell-Mediated Immunomodulation.

Gómez-Aristizábal A, Kim KP, Viswanathan S. Gómez-Aristizábal A, et al. Among authors: viswanathan s. PLoS One. 2016 Jan 28;11(1):e0147868. doi: 10.1371/journal.pone.0147868. eCollection 2016. PLoS One. 2016. PMID: 26820314 Free PMC article.

9

A Simplified Method for the Aspiration of Bone Marrow from Patients Undergoing Hip and Knee Joint Replacement for Isolating Mesenchymal Stem Cells and In Vitro Chondrogenesis.

Juneja SC, Viswanathan S, Ganguly M, Veillette C. Juneja SC, et al. Among authors: viswanathan s. Bone Marrow Res. 2016;2016:3152065. doi: 10.1155/2016/3152065. Epub 2016 Feb 11. Bone Marrow Res. 2016. PMID: 27057356 Free PMC article.

10

A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy.

Williams BA, Law AD, Routy B, denHollander N, Gupta V, Wang XH, Chaboureau A, Viswanathan S, Keating A. Williams BA, et al. Among authors: viswanathan s. Oncotarget. 2017 Jul 12;8(51):89256-89268. doi: 10.18632/oncotarget.19204. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179517 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results